| Active Not Recruiting | TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlati NCT07316829 | Fondazione IRCCS Policlinico San Matteo di Pavia | — |
| Recruiting | BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) NCT05922761 | Dana-Farber Cancer Institute | Phase 2 |
| Recruiting | Bronchial Epithelium of Children With Post-infectious Bronchiolitis Obliterans NCT06140901 | Institut National de la Santé Et de la Recherche Médicale, France | N/A |
| Completed | High Intensity Intervallic Training in Children With Bronchiolitis Obliterans NCT05881538 | Universitat Internacional de Catalunya | N/A |
| Unknown | Evaluating Bronchodilator Response in Patients With Bronchiectasis NCT05932316 | Rambam Health Care Campus | N/A |
| Terminated | Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant NCT04239989 | M.D. Anderson Cancer Center | Phase 1 |
| Recruiting | TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients NCT04098445 | Children's Hospital Medical Center, Cincinnati | — |
| Terminated | Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Impro NCT04655508 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Completed | Hp129 Xenon Imaging and BOS in Lung Transplantation NCT03603899 | Children's Hospital Medical Center, Cincinnati | Phase 1 / Phase 2 |
| Recruiting | Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome NCT04604522 | M.D. Anderson Cancer Center | — |
| Terminated | Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant ( NCT04039347 | Zambon SpA | Phase 3 |
| Completed | Study of Pulmonary MRI for the Diagnosis of Bronchiolitis Obliterans Syndrome After Allogeneic Stem Cell Trans NCT04080232 | University Hospital, Bordeaux | N/A |
| Unknown | Hyperpolarized 129Xe MRI for the Assessment of BOS With Late Onset LONIPC NCT04029636 | Hamilton Health Sciences Corporation | — |
| Completed | INSPIRE Continuation Post-Approval Study NCT03868904 | TransMedics | — |
| Completed | Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BO NCT03657342 | Zambon SpA | Phase 3 |
| Completed | Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BO NCT03656926 | Zambon SpA | Phase 3 |
| Completed | The Safety and Tolerability of Pirfenidone for BOS After HCT NCT03315741 | Stanford University | Phase 1 |
| Unknown | Measures of Respiratory Health (MRH) NCT02657837 | The Hospital for Sick Children | — |
| Unknown | Lung Function, LCI, Bronchial Inflammation and Epigenetics of Patients With BO NCT02627833 | Johann Wolfgang Goethe University Hospital | — |
| Completed | Transplant Optimization Using Functional Imaging (TROFI) NCT02441413 | FLUIDDA nv | N/A |
| Terminated | Prospective Study for Transplant Optimization Using Functional Imaging (TROFI) NCT02488304 | FLUIDDA nv | Phase 2 |
| Completed | Transplant Optimization Using Functional Imaging NCT02364674 | FLUIDDA nv | N/A |
| Unknown | MSC for Treatment of Interstitial Lung Disease After Allo-HSCT NCT02543073 | Nanfang Hospital, Southern Medical University | Phase 1 / Phase 2 |
| Completed | Microparticles and Bronchiolitis Obliterans Syndrome NCT02458274 | University Hospital, Strasbourg, France | — |
| Completed | Mesenchymal Stem Cell Therapy for Lung Rejection NCT02181712 | Mayo Clinic | Phase 1 |
| Withdrawn | Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3 NCT02109237 | The Prince Charles Hospital | N/A |
| Completed | Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoiet NCT02032381 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | LCI and Bronchial Inflammation in Patients With BO NCT02495597 | Johann Wolfgang Goethe University Hospital | — |
| Completed | Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients NCT01650545 | University of Maryland, Baltimore | Phase 1 / Phase 2 |
| Completed | Bronchial Inflammation in Patients With Bronchiolithis Obliterans NCT01633385 | Johann Wolfgang Goethe University Hospital | — |
| Completed | Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoiet NCT01273207 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Terminated | Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) NCT01439958 | Pari Pharma GmbH | Phase 3 |
| Terminated | Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotrans NCT01432080 | Maisonneuve-Rosemont Hospital | Phase 2 |
| Completed | Targeted Therapy of Bronchiolitis Obliterans Syndrome NCT01307462 | Stephanie Lee | Phase 2 |
| Completed | Forced Oscillations for Diagnosis Help in Bronchiolitis Obliterans Syndrome in Post Bone Marrow Transplantatio NCT02902471 | Hopital Foch | N/A |
| Completed | Clinical Status and Bronchial Inflammation in Patients With Bronchiolitis Obliterans NCT01327248 | Johann Wolfgang Goethe University Hospital | — |
| Completed | Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation NCT01206309 | Fred Hutchinson Cancer Center | — |
| Terminated | Efficacy Study of Azithromycin-based Therapy for Bronchiolitis Obliterans NCT01327625 | Asan Medical Center | N/A |
| Completed | Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients fo NCT01287078 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Terminated | A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD NCT01163786 | Northwestern University | Phase 2 |
| Completed | Vitamin D in Bronchiolitis Obliterans Syndrome NCT01212406 | Universitaire Ziekenhuizen KU Leuven | Phase 4 |
| Completed | Montelukast in Bronchiolitis Obliterans Syndrome NCT01211509 | Universitaire Ziekenhuizen KU Leuven | Phase 4 |
| Completed | Efficacy and Safety of Azithromycin in Patients With Bronchiolitis Obliterans NCT05299567 | Claudio Castanos | Phase 4 |
| Completed | A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung NCT01175655 | The Prince Charles Hospital | Phase 1 |
| Terminated | L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients NCT01334892 | Pari Pharma GmbH | Phase 2 / Phase 3 |
| Completed | Viral Triggers in Pediatric Lung Transplantation NCT00891865 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Montelukast to Treat Bronchiolitis Obliterans NCT00656058 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation NCT01560689 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Terminated | Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantati NCT00502554 | Hannover Medical School | N/A |
| Unknown | Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome NCT00378677 | University Medical Center Groningen | EARLY_Phase 1 |
| Completed | Prospective Evaluations of Infectious Complication in Lung Transplant Recipients NCT00177918 | University of Pittsburgh | — |
| Completed | Surveillance Study of Viral Infections Following Lung Transplantation NCT00701922 | Hannover Medical School | — |
| Completed | Effectiveness of Azithromycin Therapy in Improvement of Symptoms and Lung Function in Patients With Bronchioli NCT00563251 | Hospital Authority, Hong Kong | N/A |
| Unknown | Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Diseas NCT00163696 | Bayside Health | — |
| Completed | Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Tran NCT00141726 | University of Michigan Rogel Cancer Center | Phase 2 |
| Completed | Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation NCT00029328 | FDA Office of Orphan Products Development | Phase 1 / Phase 2 |
| Completed | Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation NCT01429844 | Universitätsklinikum Hamburg-Eppendorf | Phase 3 |
| Completed | Long-Term Study On Home Spirometry After Lung Transplantation NCT00743171 | Hannover Medical School | — |
| Completed | Immune Mechanisms of Rejection in Human Lung Allografts NCT00861900 | Washington University School of Medicine | — |
| Completed | Popcorn Lung: the Discovery of a New Disease NCT00027235 | National Center for Research Resources (NCRR) | — |
| Completed | Use of Clarithromycin in Mustard-Induced Bronchiolitis NCT00381147 | Baqiyatallah Medical Sciences University | Phase 3 |
| Completed | Use of Erythromycin in Mustard-Induced Bronchiolitis NCT00367419 | Baqiyatallah Medical Sciences University | Phase 4 |